64.22

1.59% -1.04

Handel nachbörslich: 63.50 -0.72 -1.12%

Guardant Health Inc (GH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GH? Forum Prognose

Schlusskurs vom Vortag:

$65.26

Offen:

$66.57

24-Stunden-Volumen:

2.16M

Relative Volume:

0.87

Marktkapitalisierung:

$8.01B

Einnahmen:

$692.26M

Nettoeinkommen (Verlust:

$-512.41M

KGV:

-15.15

EPS:

-4.24

Netto-Cashflow:

$-274.36M

1W Leistung:

+2.20%

1M Leistung:

+13.52%

6M Leistung:

+56.10%

1J Leistung:

+211.60%

1-Tages-Spanne:

$63.87

$66.57

1-Wochen-Bereich:

$61.70

$66.57

52-Wochen-Spanne:

$20.14

$68.00

Guardant Health Inc Stock (GH) Company Profile

Firmenname

Guardant Health Inc

Sektor

Healthcare (1141)

Branche

Diagnostics & Research (53)

Telefon

855-698-8887

Adresse

3100 HANOVER STREET, PALO ALTO

Mitarbeiter

2,021

Twitter

@guardanthealth

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

GH's Discussions on Twitter

Vergleichen Sie GH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GH Guardant Health Inc	64.22	8.14B	692.26M	-512.41M	-274.36M	-4.24
TMO Thermo Fisher Scientific Inc	524.80	201.90B	43.21B	6.58B	6.17B	17.28
DHR Danaher Corp	202.46	146.42B	24.01B	3.41B	4.86B	4.7082
IDXX Idexx Laboratories Inc	616.15	50.30B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	136.62	39.72B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	198.17	34.51B	15.70B	1.24B	2.01B	6.9036

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-25	Hochstufung	Wolfe Research	Peer Perform → Outperform
2025-09-22	Fortgesetzt	Wells Fargo	Overweight
2025-04-10	Eingeleitet	Mizuho	Outperform
2025-01-23	Eingeleitet	Barclays	Overweight
2024-06-28	Hochstufung	Guggenheim	Neutral → Buy
2024-06-03	Fortgesetzt	Jefferies	Buy
2024-04-24	Fortgesetzt	Craig Hallum	Buy
2023-12-14	Eingeleitet	Guggenheim	Neutral
2023-12-13	Eingeleitet	Wolfe Research	Peer Perform
2023-11-13	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-27	Hochstufung	Piper Sandler	Neutral → Overweight
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-05-26	Hochstufung	Citigroup	Neutral → Buy
2023-05-05	Eingeleitet	UBS	Buy
2023-03-09	Herabstufung	Citigroup	Buy → Neutral
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-11-01	Herabstufung	Piper Sandler	Overweight → Neutral
2022-10-19	Eingeleitet	Craig Hallum	Buy
2022-10-06	Eingeleitet	Stephens	Overweight
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-06-03	Eingeleitet	Piper Sandler	Overweight
2022-04-28	Fortgesetzt	BTIG Research	Buy
2022-02-24	Bestätigt	Canaccord Genuity	Buy
2022-02-24	Bestätigt	Citigroup	Buy
2022-02-24	Bestätigt	Cowen	Outperform
2022-02-24	Bestätigt	Morgan Stanley	Overweight
2022-02-24	Bestätigt	SVB Leerink	Outperform
2022-02-24	Bestätigt	Stifel	Buy
2022-02-24	Bestätigt	Wells Fargo	Overweight
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-06-15	Eingeleitet	Raymond James	Mkt Perform
2021-06-03	Eingeleitet	Goldman	Buy
2021-05-25	Eingeleitet	Wells Fargo	Overweight
2021-01-11	Eingeleitet	Stifel	Buy
2020-09-09	Eingeleitet	Morgan Stanley	Overweight
2020-06-12	Eingeleitet	BTIG Research	Buy
2020-02-21	Eingeleitet	Guggenheim	Buy
2020-01-07	Eingeleitet	Citigroup	Buy
2019-08-07	Bestätigt	Canaccord Genuity	Buy
2019-04-16	Eingeleitet	Canaccord Genuity	Buy
2019-04-10	Hochstufung	BofA/Merrill	Neutral → Buy
2019-02-28	Bestätigt	BofA/Merrill	Neutral
2018-10-29	Eingeleitet	BofA/Merrill	Neutral
2018-10-29	Eingeleitet	JP Morgan	Overweight
2018-10-29	Eingeleitet	William Blair	Outperform

Alle ansehen

Guardant Health Inc Aktie (GH) Neueste Nachrichten

Oct 10, 2025

How to track smart money flows in Guardant Health Inc.Weekly Gains Report & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Using Ichimoku Cloud for Guardant Health Inc. technicals2025 Retail Activity & High Return Stock Watch Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 - Yahoo Finance

Oct 09, 2025

CustomerThink - CustomerThink

Oct 09, 2025

Quantitative breakdown of Guardant Health Inc. recent movePortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025

Why Guardant Health Inc. (5GH) stock stays on top picksOptions Play & AI Powered Market Entry Strategies - newser.com

Oct 09, 2025

Pattern recognition hints at Guardant Health Inc. upsideTake Profit & Weekly High Conviction Trade Ideas - newser.com

Oct 09, 2025

Is Guardant Health Inc. building a consolidation base2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com

Oct 09, 2025

Abel Hall LLC Invests $202,000 in Guardant Health, Inc. $GH - MarketBeat

Oct 09, 2025

Published on: 2025-10-09 03:21:22 - newser.com

Oct 09, 2025

Guardant Health's (GH) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

What drives Guardant Health Inc 5GH stock priceAnalyst Downgrades & Market Volatility Strategies - earlytimes.in

Oct 08, 2025

Oct 07, 2025

Evercore ISI Group Raises Price Target for Guardant Health (GH) to $68 | GH Stock News - GuruFocus

Oct 07, 2025

Evercore ISI Raises Guardant Health (NASDAQ:GH) Price Target to $68.00 - MarketBeat

Oct 07, 2025

Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire

Oct 06, 2025

Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance

Oct 06, 2025

Is Guardant Health Inc. (5GH) stock dividend growth reliableTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 06, 2025

Visualizing Guardant Health Inc. stock with heatmapsCPI Data & Weekly Return Optimization Plans - newser.com

Oct 06, 2025

What momentum shifts mean for Guardant Health Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com

Oct 06, 2025

Using economic indicators to assess Guardant Health Inc. potentialJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Guardant Health Inc Stock Analysis and ForecastMarket Liquidity Analysis & Rapid Capital Trading Plans - earlytimes.in

Oct 05, 2025

Shareholders in Guardant Health (NASDAQ:GH) Are in the Red If They Invested Three Years Ago - 富途牛牛

Oct 05, 2025

Oct 03, 2025

Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic - MSN

Oct 03, 2025

How FDA Approval of Guardant360 CDx as Companion Diagnostic Could Impact Guardant Health (GH) Investors - Yahoo Finance

Oct 03, 2025

Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance

Oct 03, 2025

How to use a screener to detect Guardant Health Inc. breakoutsTrade Risk Report & Smart Money Movement Alerts - newser.com

Oct 03, 2025

What Does the Market Think About Guardant Health Inc? - Sahm

Oct 03, 2025

Oct 02, 2025

Comparing Guardant Health Inc. in custom built stock radarsJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com

Oct 02, 2025

Risk adjusted return profile for Guardant Health Inc. analyzedMarket Sentiment Report & Daily Momentum Trading Reports - newser.com

Oct 02, 2025

Barclays Raises Price Target for Guardant Health (GH) to $70.00 | GH Stock News - GuruFocus

Oct 02, 2025

4,782 Shares in Guardant Health, Inc. $GH Purchased by Trivium Point Advisory LLC - MarketBeat

Oct 02, 2025

Oct 01, 2025

GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire

Oct 01, 2025

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance

Oct 01, 2025

Sicart Associates LLC Increases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat

Oct 01, 2025

Sep 30, 2025